Skip to main content
SpringerLink
Log in

Clinical and Public Health Implications of Antimalarial Drug Resistance

  • Chapter
Antimalarial Chemotherapy

Part of the book series: Infectious Disease ((ID))

  • 447 Accesses

Abstract

With 41% of the world’s population at risk of malaria, with as many as 400 million new clinical cases and 1.5–2.7 million deaths occurring each year, malaria is a major public health threat (1). In the fight against malaria, antimalarial chemotherapy is, and will remain for the foreseeable future, the most fundamental component of malaria control (2). Although other control strategies have shown promise in reducing malaria-associated morbidity and mortality, the need for people living in areas with malaria transmission to have ready access to effective antimalarial drugs remains essential.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Health Organization. World malaria situation in 1993, part I. Weekly Epidemiol Rec 1996; 71: 17–22.

    Google Scholar 

  2. O11iaro P, Cattani J, Wirth D. Malaria: the submerged disease. JAMA, 1996; 275 (3): 230–234.

    Article  PubMed  CAS  Google Scholar 

  3. White NJ. Drug resistance in malaria. Br Med Bull 1998; 54 (3): 703–715.

    Article  PubMed  CAS  Google Scholar 

  4. McCombie SC Treatment seeking for malaria: a review of recent research. Soc Sci Med 1996;43:933–945.

    Google Scholar 

  5. Mtango FDE, Neuvians D, Broome CV, Hightower AW, Pio A. Risk factors for deaths in children under 5 years old in Bagamoyo District, Tanzania. Trop Med Parasitol 43: 1992; 229–233.

    PubMed  CAS  Google Scholar 

  6. Foster SD. Pricing, distribution, and use of antimalarial drugs. Bull WHO 1991; 69: 349–363.

    PubMed  CAS  Google Scholar 

  7. Bruce-Chwatt U, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH. Chemotherapy of Malaria. Geneva: World Health Organization, 1986.

    Google Scholar 

  8. Lobel HO, Campbell CC. Malaria prophylaxis and distribution of drug resistance. Clin Trop Med Commun Dis 1986; 1: 225–242.

    Google Scholar 

  9. Hey J. Parasite populations: the puzzle of Plasmodium. Curr Biol 1999; 9: 565–567.

    Article  Google Scholar 

  10. Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, et al. A primary malarial infection is composed of a very wide range of genetically diverse but related parasites. J Clin Invest 1998; 101 (9): 2008–2016.

    Article  PubMed  CAS  Google Scholar 

  11. White NJ. Assessment of the pharmacological properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997; 41 (7): 1413–1422.

    PubMed  CAS  Google Scholar 

  12. White NJ, 011iaro PL. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today, 12 1996; (19): 399–401.

    Article  PubMed  CAS  Google Scholar 

  13. Thaithong S, Suebsaeng L, Rooney W, Beale GH. Evidence of increased chloroquine sensitivity in Thai isolates of Plasmodium falciparum. Trans R Soc Trop Med 1988;Hyg; 82: 37–38.

    Google Scholar 

  14. Liu D, Liu R, Ren D, Gao D, Zhang C, Qui C, et al. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull WHO 1995; 73: 483–486.

    PubMed  CAS  Google Scholar 

  15. Watkins WM, Mberu EK, Winstanley PA, Plowe CV. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokientic analyses. Parasitol Today 1997; 13 (12): 459–464.

    Article  PubMed  CAS  Google Scholar 

  16. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med 1996; Hyg; 54 (1): 62–66.

    CAS  Google Scholar 

  17. Hill WG, Babiker HA, Ranford-Cartwright LC, Walliker D. Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to estimation of clonality in malaria parasites. Genet Res 1995; 65 (1): 53–61.

    Article  PubMed  CAS  Google Scholar 

  18. Dye C, Willimas BG. Multigenic resistance among inbred malaria parasites. Proc R Soc London Ser B 1997; 264: 61–67.

    Article  CAS  Google Scholar 

  19. Hastings IM. A model for the origins and spread of drug resistant malaria. Parasitology 1997; 115: 133–141.

    Article  PubMed  Google Scholar 

  20. Hastings IM, Mackinnon MJ. The emergence of drug-resistant malaria. Parasitology 1998; 117: 411–417.

    Article  PubMed  Google Scholar 

  21. Mackinnon MT, Hastings IM. The evolution of multiple drug resistance in malaria parasites. Trans R Soc Trop Med Hyg 92: 1998; 188–195.

    Article  PubMed  CAS  Google Scholar 

  22. WHO Resistance of malaria Parasites to Drugs. Report of a WHO Scientific Group. Geneva: WHO, 1965.

    Google Scholar 

  23. WHO Assessment of therapeutic efficacy of antimalarial drugs-for uncomplicated falciparum malaria in areas with intense transmission. WHO Report WHO/MAL/96.1077 (1996).

    Google Scholar 

  24. Dejardins RE, Canfield CT, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activiy in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979; 16: 710–718.

    Article  Google Scholar 

  25. Druilhe P, Mazier D, Brandicourt O, Gentilini M. One-step Plasmodium falciparum cultivation-application to in vitro drugs testing. Tropenmed Parasitol 34: 1983; 233–234.

    PubMed  CAS  Google Scholar 

  26. Le Bras J, Deloron P. In vitor study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am J Trop Med Hyg 1983; 32: 447–451.

    PubMed  Google Scholar 

  27. Makler MT, Ries JM, Williams JA, Bacroft JE, Piper RC, Gibbins BL, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug susceptibility assay. Am J Trop Med Hyg 1993; 48: 739–741.

    PubMed  CAS  Google Scholar 

  28. Basco LK, Marquet F, Makler MT, Le Bras J. Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. Exp Parasitol 1995; 80: 260–271.

    Article  PubMed  CAS  Google Scholar 

  29. Ringwald P, Basco LK. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon. Bull WHO 1999; 77 (1): 34–43.

    PubMed  CAS  Google Scholar 

  30. Plowe C, Kublin JG, Doumbo OK. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role of clinical resistance to antifolates. Drug Resist Updates 1998; 1: 389–396.

    Article  CAS  Google Scholar 

  31. Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, et al. Resistance to antifolates in Plasmodium falciparum, monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in large number of field samples of diverse origins. Mol. Biochem. Parasitol. 1997; 8: 161–177.

    Article  Google Scholar 

  32. Collins WE, Jeffrey GM. A retrospective examination of sporozoite-and trophozoiteinduced infections with Plasmodium falciparum. Am J Trop Med Hyg 1999; 61 (Suppl 1): 1–48.

    Google Scholar 

  33. White NJ, Krishna S. Treatment of malaria; some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg 1989; 83: 767–777.

    Article  PubMed  CAS  Google Scholar 

  34. White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997;41(7):1413–1422.

    Google Scholar 

  35. Ter Kuile FO, Nosten F, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, White NJ. Predictors of mefloquine treatment failure: a prospective study in 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995; 660–664.

    Google Scholar 

  36. Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 1998; 3: 543–552.

    Article  PubMed  CAS  Google Scholar 

  37. Handunnetti SM, Gunewardena DM, Pathirana PP, Ekanayake K, Weerasinghe SM. Features of recrudescent chloroquine-resistant Plasmodium, falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med 1996;Hyg; 90: 563–567.

    Google Scholar 

  38. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R, Campbell CC. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993; 167: 932–937.

    Article  PubMed  CAS  Google Scholar 

  39. Barat LM, Hinonga B, Nkunika S, Ettling M, Ruebush TK, Kapelwa W, et al. A systematic approach to the development of a rational malaria treatment policy in Zambia. Trop Med Int Health 1998; 3: 535–542.

    Article  PubMed  CAS  Google Scholar 

  40. Smithuis FM, van Woensel JBM, Nordlander E, Sok Vantha W, ter Kuile FO. Comparison of two mefloquine regimens for treatment of falciparum malaria on the north-eastern Thai-Cambodian border. Antimicrob Agents Chemother 1993; 37: 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  41. Luby SP, Kazembe PN, Redd SC, Ziba C, Nwanyanwu OC, Hightower AW, et al. Using clinical signs to diagnose anaemia in African children. Bull WHO 1995; 73: 477–482.

    PubMed  CAS  Google Scholar 

  42. Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull WHO 1989; 67 (2): 189–196.

    PubMed  CAS  Google Scholar 

  43. Greenberg AE, Nguyen-Dinh P, Mann JM, Kabote N, Colebunders RL, Francis H, et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA 1988; 259: 545–549.

    Article  PubMed  CAS  Google Scholar 

  44. Zucker JR, Lackritz EM, Ruebsuh TK, Hightower AW, Adungosi JE, Were JBO, et al. Anaemia, blood transfusion practices, HIV and mortality among women of reproductive age in western Kenya. Trans R Soc Trop Med Hyg 1994; 88: 173–176.

    Article  PubMed  CAS  Google Scholar 

  45. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS 12 (Suppl A); 1998: S81 - S86.

    PubMed  Google Scholar 

  46. Redd SC, Wirima JJ, Steketee RW. Risk factors for anemia in young children in rural Malawi. Am J Trop Med Hyg. 1994; 51: 170–174.

    Google Scholar 

  47. Cornet M, Le Hasran J-Y, Fievet N, Cot M, Personne P, Gounoue R, et al. Prevalence of and risk factors for anemia in young children in South-Cameroon. Am J Trop Med Hyg 1998; 58: 606–611.

    PubMed  CAS  Google Scholar 

  48. McCormick MC. The contribution of low birth weight to infant mortality and childhood mortality. N Engl J Med 1985; 312: 82–90.

    Article  PubMed  CAS  Google Scholar 

  49. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, et al. Impairment of a pregnant woman’s acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type 1. Am J Trop Med Hyg 1996; 55 (Suppl 1): 33–41.

    PubMed  CAS  Google Scholar 

  50. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, et al. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. Am J Trop Med Hyg 1996; 55, (Suppl 1): 24–32.

    PubMed  CAS  Google Scholar 

  51. Steketee RW, Wirima JJ, Slutsker L, McDermott IM, Hightower AW, et al. Malaria Prevention in Pregnancy. The Effects of Treatment and Chemoprophylaxis on Placental Malaria Infection, Low Birth Weight, and Fetal, Infant, and Child Survival (African Child Survival Initiative-Combating Childhood Communicable Diseases Project Document 099–4048 ). Atlanta, GA: Centers for Disease Control and Prevention, 1993.

    Google Scholar 

  52. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 1994; 51: 515–522.

    PubMed  CAS  Google Scholar 

  53. Parise ME, Ayisi JG, Nahlen BL, Schultz U. Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59: 813–822.

    PubMed  CAS  Google Scholar 

  54. Menedez C. Malaria during pregnancy: a priority area for malaria research and control. Parasitol Today 1995; 11: 178–183.

    Article  Google Scholar 

  55. Warsame M, Wernsdorfer WH, Ericsson Ö, Björkman A. Isolated malaria outbreak in Somalia: role of chloroquine-resistant Plasmodium falciparum demonstrated in Balcad epidemic. J Trop Med Hyg 1990; 93: 284–289.

    PubMed  CAS  Google Scholar 

  56. Malakooti MA, Biomndo K, Shanks GD. Reemergence of epidemic malaria in the highlands of western Kenya. Emerg Infect Dis 1998; 4 (4): 671–676.

    Article  PubMed  CAS  Google Scholar 

  57. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 1999; 60 (6): 1019–1023.

    PubMed  CAS  Google Scholar 

  58. Price RN, Nosten F, Luxemberger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artmisinin derivatives on malaria transmissibility. Lancet 1996; 347: 1654–1658.

    Article  PubMed  CAS  Google Scholar 

  59. Handunnetti SM, Gunewardena, Pathirana PPSL, Ekanayake K, Weerasinghe S, Mendis KN. Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med 1996;Hyg; 90: 563–567.

    Google Scholar 

  60. Hogh B, Gamage-Mendis A, Butcher GA, Thompson R, Begtrup K, Mendis C, et al. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg. 1998; 58 (2): 176–182.

    PubMed  CAS  Google Scholar 

  61. Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H. Chloroquine resistance of Plasmodium falciparum: a biological advantage? Trans R Soc Trop Med 1995;Hyg; 89: 90–91.

    Google Scholar 

  62. Warsame M, Wernsdorfer WH, Payne D, Björkman A. Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamine in Somalia: relationships between the responses to the different drugs. Trans R Soc Trop Med 1991;Hyg; 85: 565–569.

    Google Scholar 

  63. Rathod PK, McErlean T, Lee PC. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 1997; 94: 9389–9393.

    Article  PubMed  CAS  Google Scholar 

  64. Wilkinson RN, Noeypatimanondh S, Gould DJ. Infectivity of falciparum malaria patients for anopheline mosquitoes before and after chloroquine treatment. Trans R Soc Trop Med Hyg 1976; 70: 306–307.

    Article  PubMed  CAS  Google Scholar 

  65. Sucharit S, Surathin K, Tumrasvin W, Sucharit P. Chloroquine resistant Plasmodium falciparum in Thailand: susceptibility of Anopheles. J Med Assoc Thai 1977; 60: 648–654.

    PubMed  CAS  Google Scholar 

  66. Kachur SP, Nicholas E, Jean-Francois V, Benitez A, Bloland PB, Saint Jean Y, et al. Prevalence of malaria parasitemia and accuracy of microscopic diagnosis in Haiti, October 1995. Pan Am J Public Health 1998; 3: 35–39.

    CAS  Google Scholar 

  67. Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria? Parasitology Today 1991; 7: 277–281.

    Article  PubMed  CAS  Google Scholar 

  68. White N. Antimalarial drug resistance and mortality in falciparum malaria. Trop Med Int Health 1999; 4: 469–470.

    Article  PubMed  CAS  Google Scholar 

  69. Marsh K. Malaria-a neglected disease? Parasitology 1992; 104: S53 - S69.

    Article  PubMed  Google Scholar 

  70. Zucker JR, Lackrtiz EM, Ruebush TK, Hightower AW, Adungosi JE, Were JBO, et al. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg 1996; 55: 655–660.

    PubMed  CAS  Google Scholar 

  71. Trape J-F, Pison G, Preziosi M-P, Enel C, Desgrées du Loft A, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. CR Acad Sci Paris, Sci Vie 1998; 321: 689–697.

    CAS  Google Scholar 

  72. Hoffman SL, Masbar S, Hussein PR, Soewart A, Harun S, Marwoto HA, et al. Absence of malaria mortality in villagers with chloroquine-resistance Plasmodium falciparum treated with chloroquine. Trans R Soc Trop Med Hyg 1984; 78: 175–178;

    Google Scholar 

  73. Evans DB, Hurley SF. The application of economic evaluation techniques in the health sector: the state of the art. J Int Dev 7 (3): 1995; 503–524.

    Article  Google Scholar 

  74. Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 1999; 354 (9176): 378–385.

    Article  PubMed  CAS  Google Scholar 

  75. Murray CJL, Lopez AD. The Global burden of disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health (on behalf of WHO and the World Bank), 1996.

    Google Scholar 

  76. Phillips M, Phillips-Howard PA. Economic implications of resistance to antimalarial drugs. Pharmacoeconomics 1996; 10 (3): 225–238.

    Article  PubMed  CAS  Google Scholar 

  77. Sudre P, Breman JG, McFarland D, Koplan JP. Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol 1992; 21 (1): 146–154.

    Article  PubMed  CAS  Google Scholar 

  78. Schapira A, Beales PF, Halloran ME. Malaria-living with drug-resistance. Parasitol Today 1993; 9 (5): 168–174.

    Article  PubMed  CAS  Google Scholar 

  79. Coast J, Smith RD, Millar MR. Superbugs-should antimicrobial resistance be included as a cost in economic-evaluation. Health Econ 1996; 5 (3): 217–226.

    Article  PubMed  CAS  Google Scholar 

  80. Coast J, Smith RD, Millar MR. An economic perspective on policy to reduce antimicrobial resistance. Soc Sci Med 1998; 46 (1): 29–39.

    Article  PubMed  CAS  Google Scholar 

  81. Ridley RG. Plasmodium: drug discovery and development-an industrial perspective. Exp Parasitol, 1997;87:293–304.

    Google Scholar 

  82. Trouiller P, Olliaro PL. Drug development output: what proportion for tropical diseases? Lancet 1999; 354 (9173): 164.

    Article  PubMed  CAS  Google Scholar 

  83. O11iaro PL, Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther. 1999; 81 (2): 91–110.

    Article  PubMed  CAS  Google Scholar 

  84. Gardner MJ The genome of the malaria parasite. Curr Opin Genet Dev 1999; 9 (6): 704–708.

    Article  PubMed  CAS  Google Scholar 

  85. Melton L. From DNA to drugs. Novartis Foundation Symposium. From genome to therapy: integrating new technologies with drug development. Mol Med Today 1999; 5 (11): 468–469.

    Article  PubMed  CAS  Google Scholar 

  86. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, et al. Averting a malaria disaster. Lancet 1999; 353 (9168): 1965–7.

    Article  PubMed  CAS  Google Scholar 

  87. Wongsrichanalai C, Wimonwattrawatee T, Sookto P, Laoboonchai A, Heppner DG, Kyle DE, et al. In vitro sensitivity of Plasmodium. falciparum to artesunate in Thailand. Bull WHO 1999; 77: 392–98.

    PubMed  CAS  Google Scholar 

  88. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91 (5): 574–577.

    Article  PubMed  CAS  Google Scholar 

  89. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347 (9016): 1654–1658.

    Article  PubMed  CAS  Google Scholar 

  90. White N. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc London B 1999; 354: 739–749.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Piero L. Olliaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter B. Bloland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, University of California, San Francisco, CA, USA

    Philip J. Rosenthal MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Olliaro, P.L., Bloland, P.B. (2001). Clinical and Public Health Implications of Antimalarial Drug Resistance. In: Rosenthal, P.J. (eds) Antimalarial Chemotherapy. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-111-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-111-4_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-124-0

  • Online ISBN: 978-1-59259-111-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation